Guohao Li
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
ATP13A2 promoted cell stemness, cisplatin resistance, autophagy, and cell progression of bladder cancer.
Journal: Frontiers in immunology
Published: November 10, 2025
PIEZO1 mediates matrix stiffness-induced tumor progression in kidney renal clear cell carcinoma by activating the Ca2+/Calpain/YAP pathway.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: March 26, 2024
1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/LDHB axis.
Journal: Cell communication and signaling : CCS
Published: November 20, 2023
Theaflavin pretreatment ameliorates renal ischemia/reperfusion injury by attenuating apoptosis and oxidative stress in vivo and in vitro.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 07, 2023
Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression.
Journal: Aging and disease
Published: October 24, 2022
Corrigendum to CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/m-TOR pathway in vitro and in vivo: [Urol Oncol. 2018 Jun;36(6):312.e1-312.e8. / URO-D-17-00654R1].
Journal: Urologic oncology
Published: October 10, 2022
circITGA7 Acts as a miR-370-3p Sponge to Suppress the Proliferation of Prostate Cancer.
Journal: Journal of oncology
Published: September 19, 2021
Theaflavin ameliorates renal ischemia/reperfusion injury by activating the Nrf2 signalling pathway in vivo and in vitro.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 31, 2020
A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer.
Journal: The International journal of biological markers
Published: April 28, 2020
Efficacy of bladder perfusion of alternating hydroxycamptothecin and gemcitabine combined with low-dose tuberculin in the treatment of non-muscle invasive bladder cancer after TURBT.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: October 25, 2019
A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma.
Journal: Disease markers
Published: July 19, 2019
Last Updated: 09/26/2026